Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model

Epstein–Barr virus (EBV) is etiologically associated with a number of malignant and non-malignant conditions. Thus, a prophylactic vaccine against this virus could help to reduce the burden of many EBV-associated diseases. Previously, we reported that an EBV virus-like particle (VLP) vaccine was hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Reguraman, Narendran, Hassani, Asma, Philip, Pretty S., Pich, Dagmar, Hammerschmidt, Wolfgang, Khan, Gulfaraz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058710/
https://www.ncbi.nlm.nih.gov/pubmed/36992124
http://dx.doi.org/10.3390/vaccines11030540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058710/
https://www.ncbi.nlm.nih.gov/pubmed/36992124
http://dx.doi.org/10.3390/vaccines11030540

Ejemplares similares